PPARδ agonist 8 structure
|
Common Name | PPARδ agonist 8 | ||
|---|---|---|---|---|
| CAS Number | 2697129-55-6 | Molecular Weight | 423.50 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H29NO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PPARδ agonist 8Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2)[1]. |
| Name | PPARδ agonist 8 |
|---|
| Description | Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C25H29NO5 |
|---|---|
| Molecular Weight | 423.50 |
| InChIKey | DHSPANNHTRRKRI-UHFFFAOYSA-N |
| SMILES | COc1nc2ccccc2cc1C(O)CCc1cc(C)c(OC(C)(C)C(=O)O)c(C)c1 |